CXCL12 and neoplasm: CXCL12 can be produced by hyperCAF, the binding of CXCL12 to tumor cells can inhibit tumor cell apoptosis and change the characteristics of tumor cell adhesion (Augsten et al., 2014; Zhao et al., 2017).